NCT06302855

Exploring Adherence and Knowledge Among Diabetic Individuals in Periodontal Care

Karim Gariani·ClinicalTrials.gov·diagnostic testNot yet recruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Periodontitis
Drug/Device/Intervention
dental expertise
Study type
Interventional
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Karim Gariani
Funder
University Hospital, Geneva
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2024
End date
Sep 01, 2026
Enrollment
180 participants
Primary outcome

adherence of diabetic patients to periodontal

Summary

Objective(s) The primary objective is to evaluate the adherence of diabetic patients to
 periodontal care, accomplished either through oral communication (group A, control) or
 through a photograph of their smile, and focusing on their gum health evaluated by a
 periodontist (group B, test).
 
 Secondary objectives include assessing the prevalence of periodontal disease (PD) in this
 diabetic sample population and evaluating the presence of specific biomarkers related to it.
 
 The final objective is to assess the agreement between the diagnosis of periodontitis based
 on the photographs and the diagnosis given after the dental visit, based on the clinical
 examination. The aim is to determine if the photos could potentially serve as a reliable
 indicator for periodontal risk assessment.

ICD-10 classifications
Chronic periodontitisPeriodontosisAcute periodontitisChronic apical periodontitisPeriodontal disease, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06302855
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06302855 through Pure Global AI's free database. This phase not specified trial is sponsored by Karim Gariani and is currently Not yet recruiting. The study focuses on Periodontitis. Target enrollment is 180 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.